The discovery of a signalling axis that connects nicotine responses in the brain with glucose metabolism by the pancreas sheds light on why cigarette smoking increases the risk of diabetes. One of the many dangers of smoking is an increased risk of diabetes, because nicotine uptake leads to altered glucose metabolism and increased blood sugar...
Tag: <span>Pancreas</span>
Artificial pancreas system better controls blood glucose levels than current technology
NIH-funded study based at CU Anschutz and other centers show safety, efficacy benefits for people with type 1 diabetes UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS AURORA, Colo. (Oct. 17, 2019) – A multicenter randomized clinical trial evaluating a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — has found that...
Our bodies may cure themselves of diabetes in the future
Researchers have found that neighbour-cells can take over functions of damaged or missing insulin-producing cells; the discovery may lead to new treatments for diabetes. IMAGE: LUIZA GHILA IS DOING RESEARCH ON FLEXIBLE CELLS TO CURE DIABETES. CREDIT: KIM E. ANDREASSEN Diabetes is caused by damaged or non-existing insulin cells inability to produce insulin, a hormone that is...
Could you have silent gallstones?
The gallbladder is a small organ in the upper right abdomen. It’s a reservoir for bile, the fluid made by the liver to aid digestion. Experts aren’t sure why, but gallstones form from imbalances in the substances that make up bile, such as cholesterol. You can have one or hundreds of gallstones, and they can...
Uncovering the whole story in diabetes
More than 400 million people worldwide suffer from type 2 diabetes, a disease characterized by increased blood glucose levels because the body’s normal way of controlling insulin release breaks down. But insulin is only one half of the story about what goes wrong in type 2 diabetes: the release of another hormone called glucagon, which...
DPP-4I not tied to increased risk of acute pancreatitis in seniors
(HealthDay)—For older adults, dipeptidyl peptidase 4 inhibitors (DPP-4Is) are not associated with increased risk of acute pancreatitis, according to a study published online April 4 in Diabetes Care. Jin-Liern Hong, Ph.D., from the University of North Carolina at Chapel Hill, and colleagues examined the risks of acute pancreatitis among U.S. Medicare beneficiaries, aged 66+ years, initiating DDP-4Is versus...
- 1
- 2